BTC$59,714.00-0.62%
ETH$1,573.600.00%
USDT$0.9983-0.03%
BNB$550.56-1.09%
USDC$0.9996-0.02%
XRP$1.04-0.65%
SOL$71.69+1.33%
TRX$0.3219-0.10%
FIGR_HELOC$1.04+0.00%
HYPE$62.02-0.16%
DOGE$0.0723-2.37%
USDS$0.9994-0.03%
RAIN$0.0156-0.06%
LEO$9.43-0.30%
ZEC$377.38-4.92%
XLM$0.1722-0.21%
BTC$59,714.00-0.62%
ETH$1,573.600.00%
USDT$0.9983-0.03%
BNB$550.56-1.09%
USDC$0.9996-0.02%
XRP$1.04-0.65%
SOL$71.69+1.33%
TRX$0.3219-0.10%
FIGR_HELOC$1.04+0.00%
HYPE$62.02-0.16%
DOGE$0.0723-2.37%
USDS$0.9994-0.03%
RAIN$0.0156-0.06%
LEO$9.43-0.30%
ZEC$377.38-4.92%
XLM$0.1722-0.21%
Tango Therapeutics stock fell after announcing a $210 million equity offering priced at $8.66 per share, raising funds from major investors like Farallon Capital and T. Rowe Price.